Ahead Therapeutics attended the 3rd Antigen-specific immune tolerance summit last February

The meeting took place on the 26th-27th of February in Boston (https://as-immunetolerance.com). Large pharma & biotech companies and academic researchers participated in conversations with a focus on overcoming the complexity of autoimmune-mediated disorders, expanding opportunities through combination strategies and, undertaking a more precise antigen-specific approach for novel drug development.